Bunzl (ADR) Earnings Calls
| Release date | Mar 02, 2026 |
| EPS estimate | $0.669 |
| EPS actual | $0.676 |
| EPS Surprise | 1.05% |
| Revenue estimate | 8.168B |
| Revenue actual | 8.13B |
| Revenue Surprise | -0.459% |
| Release date | Aug 26, 2025 |
| EPS estimate | $1.05 |
| EPS actual | $0.756 |
| EPS Surprise | -28.00% |
| Revenue estimate | 7.834B |
| Revenue actual | 7.849B |
| Revenue Surprise | 0.191% |
| Release date | Apr 24, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Mar 03, 2025 |
| EPS estimate | $0.120 |
| EPS actual | $1.13 |
| EPS Surprise | 841.67% |
| Revenue estimate | 7.551B |
| Revenue actual | 7.588B |
| Revenue Surprise | 0.494% |
Last 4 Quarters for Bunzl (ADR)
Below you can see how BZLFY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 03, 2025 |
| Price on release | $19.39 |
| EPS estimate | $0.120 |
| EPS actual | $1.13 |
| EPS surprise | 841.67% |
| Date | Price |
|---|---|
| Feb 25, 2025 | $20.99 |
| Feb 26, 2025 | $21.39 |
| Feb 27, 2025 | $20.96 |
| Feb 28, 2025 | $21.20 |
| Mar 03, 2025 | $19.39 |
| Mar 04, 2025 | $19.43 |
| Mar 05, 2025 | $19.79 |
| Mar 06, 2025 | $19.35 |
| Mar 07, 2025 | $19.88 |
| 4 days before | -7.62% |
| 4 days after | 2.53% |
| On release day | 0.310% |
| Change in period | -5.29% |
| Release date | Apr 24, 2025 |
| Price on release | $15.51 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 17, 2025 | $15.21 |
| Apr 21, 2025 | $14.95 |
| Apr 22, 2025 | $15.87 |
| Apr 23, 2025 | $15.85 |
| Apr 24, 2025 | $15.51 |
| Apr 25, 2025 | $15.48 |
| Apr 28, 2025 | $15.47 |
| Apr 29, 2025 | $15.49 |
| Apr 30, 2025 | $15.65 |
| 4 days before | 1.97% |
| 4 days after | 0.90% |
| On release day | -0.129% |
| Change in period | 2.89% |
| Release date | Aug 26, 2025 |
| Price on release | $17.01 |
| EPS estimate | $1.05 |
| EPS actual | $0.756 |
| EPS surprise | -28.00% |
| Date | Price |
|---|---|
| Aug 20, 2025 | $15.97 |
| Aug 21, 2025 | $15.96 |
| Aug 22, 2025 | $16.15 |
| Aug 25, 2025 | $16.02 |
| Aug 26, 2025 | $17.01 |
| Aug 27, 2025 | $16.82 |
| Aug 28, 2025 | $16.90 |
| Aug 29, 2025 | $17.01 |
| Sep 02, 2025 | $16.92 |
| 4 days before | 6.51% |
| 4 days after | -0.529% |
| On release day | -1.12% |
| Change in period | 5.95% |
| Release date | Mar 02, 2026 |
| Price on release | $15.02 |
| EPS estimate | $0.669 |
| EPS actual | $0.676 |
| EPS surprise | 1.05% |
| Date | Price |
|---|---|
| Feb 24, 2026 | $14.54 |
| Feb 25, 2026 | $14.55 |
| Feb 26, 2026 | $14.60 |
| Feb 27, 2026 | $14.83 |
| Mar 02, 2026 | $15.02 |
| Mar 03, 2026 | $14.80 |
| Mar 04, 2026 | $14.60 |
| Mar 05, 2026 | $14.92 |
| Mar 06, 2026 | $14.82 |
| 4 days before | 3.30% |
| 4 days after | -1.33% |
| On release day | -1.46% |
| Change in period | 1.93% |
Bunzl (ADR) Earnings Call Transcript Summary of Q4 2025
Bunzl reported a challenging 2025 with group revenue up 3.0% (0.4% underlying) but adjusted operating profit down ~4% (adjusted operating margin 7.6% vs 8.3% in 2024). The primary drag was execution and margin pressure in North America distribution after an organizational change, amplified by weaker end markets (foodservice, convenience, food processors) and some tariff-related supply cost pressure. Management implemented leadership changes, returned pricing and inventory control to local teams, restored service levels and reengaged the salesforce; these actions helped moderate the margin decline in H2 and produced underlying revenue growth in H2 and over $100m of new business wins in Q4. Cash generation remained strong: free cash flow of GBP 579m, cash conversion ~95%, and adjusted net debt/EBITDA around 2.0x (within target 2–2.5x). Bunzl completed 8 (smaller) acquisitions in 2025 (GBP 132m) and has an active pipeline; bolt-on M&A remains a core growth lever. Management reiterated 2026 guidance: moderate revenue growth, slightly down operating margin versus 2025 (ex-share-based credit), a more balanced H1/H2 profit phasing, expected net finance charge ~GBP 125m and tax rate ~26%. Capital allocation priorities unchanged: invest for organic growth, progressive dividend (dividend +0.3%), self-fund value-accretive acquisitions, and return excess cash. Key investor implications: recovery signs via H2 momentum and operational fixes, strong cash/capital flexibility and an active M&A pipeline provide upside, but near-term margin and revenue sensitivity remain given uncertain macro and sector-specific demand headwinds (notably North America, Brazil, and French cleaning & hygiene).
Sign In
Buy BZLFY